Skip to Main Content

Paper Details

Heart failure, peripheral artery disease, and dapagliflozin: a patient-level meta-analysis of DAPA-HF and DELIVER.
Eur Heart J
5
2023
DAPA, HF, Heart failure, PAD, Peripheral artery disease, amputation, canagliflozin, cardiovascular death, dapagliflozin, glucose, heart failure, ischaemia, patient, patients, peripheral artery disease, person, sodium, sodium-glucose cotransporter 2
Author NameAffiliation
Adrian F HernandezDuke University Medical Center
Carolyn S P Lam
Carolyn S P LamDuke-National University of Singapore
Rudolf A de BoerErasmus Medical Center
Mikhail KosiborodSaint Luke's Mid America Heart Institute
Akshay S DesaiBrigham and Women's Hospital, Harvard Medical School
Marc S SabatineBrigham and Women's Hospital
Marc S SabatineBrigham and Women's Hospital
  • 1 - 8

Datasets

Release 1.2